IN THE SPOTLIGHT

Structure-based identification, phosphorylation, cyclization and engineering of a self-binding peptide carboxy-terminal to EGFR kinase domain by integrating dynamics simulation, energetics calculation and fluorescence analysis

Structure-based identification, phosphorylation, cyclization and engineering of a self-binding peptide carboxy-terminal to EGFR kinase domain by integrating dynamics simulation, energetics calculation and fluorescence analysis

Implantation awakens peri-implant osteogenic potential via Snx5-EGFR axis-mediated mechanical transduction

Implantation awakens peri-implant osteogenic potential via Snx5-EGFR axis-mediated mechanical transduction

Dynamic dual regulation of amphiregulin in liver pathophysiology: balancing regeneration and disease progression via the EGFR axis

Dynamic dual regulation of amphiregulin in liver pathophysiology: balancing regeneration and disease progression via the EGFR axis

Germ-line exon 21 EGFR V831H mutation in advanced NSCLC resistance to almonertinib: a case report

Germ-line exon 21 EGFR V831H mutation in advanced NSCLC resistance to almonertinib: a case report

Macrophage-Derived Amphiregulin Enhances Schwann Cell Phagocytosis Through the EGFR/CTSS Signaling Pathway

Macrophage-Derived Amphiregulin Enhances Schwann Cell Phagocytosis Through the EGFR/CTSS Signaling Pathway

FDA Approves Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the Only EGFR-Targeted Therapy that can be Administered Once a Month

FDA Approves Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the Only EGFR-Targeted Therapy that can be Administered Once a Month

Radiotherapy has a role to play in patients with EGFR-mutated non-small-cell lung cancer in first-line treatment

Radiotherapy has a role to play in patients with EGFR-mutated non-small-cell lung cancer in first-line treatment